After GLP-1 Weight Loss, Stop Chasing the Lowest Number
Why composition-first maintenance is a better goal after Ozempic, Wegovy or Mounjaro.
Read moreChoose a category to find plain-language guides, clinical evidence updates, practical tools and evidence-based articles.
Browse by category
Why composition-first maintenance is a better goal after Ozempic, Wegovy or Mounjaro.
Read moreMetabolism, calories, exercise, appetite, medicines and regain prevention in plain language.
Read moreWegovy for MASH, Mounjaro cardiovascular data, eye safety, pregnancy evidence and new oral GLP-1 research.
Read moreWhat changed this month, what matters for patients, and what Élan believes now.
Read moreCheck whether your plan is ready before reducing, stopping or maintaining after Ozempic, Wegovy or Mounjaro.
Use the toolEstimate a practical protein target based on ideal body weight, with lower-calorie protein ideas.
Use the calculatorHow appetite, biology and environment affect regain, and why the useful response is a maintenance system rather than blame.
Read moreWhat quieter appetite can make possible, what risks to watch for, and what to build before hunger returns.
Read moreHow texture, eating speed, protein, fibre and defaults can support satiety without forbidden-food rules.
Read moreA calm reset after one difficult meal, weekend or routine break, without fasting, punishment or all-or-nothing thinking.
Read moreA framework for choosing whether lifestyle structure, psychological support, medication assessment or combined care should lead.
Read moreWhat the clinical trials show about weight loss, tolerability, muscle and long-term maintenance.
Read moreWhat a randomised trial found about reducing to 5 mg, continuing treatment and stopping.
Read moreA structured framework for tapering, monitoring and protecting weight-loss results.
Read moreStorage, missed doses, restarts, side effects and keeping maintenance on track.
Read moreHow to tell expected appetite control from poor intake that needs review.
Read moreWhat clinical trials show, what may help and when symptoms need urgent care.
Read moreWhy constipation happens, what practical steps may help and when to contact a doctor.
Read moreWhat the evidence says, which symptoms need prompt assessment and why the medicine is not the whole explanation.
Read moreTemporary blurred vision, diabetic retinopathy and rare NAION warnings need different responses.
Read moreWhy treatment pace, nutrition and telogen effluvium matter, and when hair loss needs assessment.
Read moreCurrent EU guidance on stop timing, a positive pregnancy test and breastfeeding.
Read moreEU guidance on paternal exposure, sperm, fertility and whether men need a washout period.
Read moreCurrent EU guidance on oral contraception, vomiting, diarrhoea and pregnancy planning.
Read moreHow current guidance handles aspiration risk, medication holds and restart planning.
Read moreWhy protein, resistance training and body composition matter during GLP-1 treatment.
Read moreWhat is proven, promising or speculative across cardiovascular, kidney, sleep-apnoea, liver and other research.
Read more